69 related articles for article (PubMed ID: 19102214)
41. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
42. MRI and PET scans for primary staging and detection of cervical cancer recurrence.
Liyanage SH; Roberts CA; Rockall AG
Womens Health (Lond); 2010 Mar; 6(2):251-67; quiz 268-9. PubMed ID: 20187730
[TBL] [Abstract][Full Text] [Related]
43. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
44. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
[TBL] [Abstract][Full Text] [Related]
45. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
Ouyang L; Shi ZY; Lin ZG
Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
[TBL] [Abstract][Full Text] [Related]
46. The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma: results of pilot study.
Dolezelova H; Slampa P; Ondrova B; Gombosova J; Sovadinova S; Novotny T; Bolcak K; Ruzickova J; Hynkova L; Forbelska M
Neoplasma; 2008; 55(5):437-41. PubMed ID: 18665755
[TBL] [Abstract][Full Text] [Related]
47. [The impact of PET in radiotherapy of the cervical carcinoma--results of pilot study].
Dolezelová H; Slampa P; Bolcák K; Gombosová J; Ondrová B; Novotný T; Hynková L; Růzicková J; Forbelská M
Ceska Gynekol; 2008 Jun; 73(3):135-40. PubMed ID: 18646663
[TBL] [Abstract][Full Text] [Related]
48. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
[TBL] [Abstract][Full Text] [Related]
49. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
50. [Use of PET/CT examination in head and neck cancer radiotherapy planning].
Kolárová I; Vanásek J; Odrázka K; Petruzelka L; Dolezel M; Nechvíl J
Klin Onkol; 2009; 22(3):98-103. PubMed ID: 19708543
[TBL] [Abstract][Full Text] [Related]
51. [The role of PET in the diagnosis and prediction of the treatment response in patients with cervical carcinoma treated with radiotherapy--results of pilot study].
Dolezelová H; Slampa P; Ondrová B; Bolcák K; Gombosová J; Sovadinová S; Novotný T; Růzicková J; Hynková L; Opletal P; Forbelská M
Klin Onkol; 2008; 21(2):66-70. PubMed ID: 19102214
[TBL] [Abstract][Full Text] [Related]
52. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
53. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
